Sessions Were Renumbered as of May 19.
Legend:
CC-W = McCormick Place Convention Center, West Building,
CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago,
UC = Conference Chicago at University Center
* = applied session ! = JSM meeting theme
490
Wed, 8/3/2016,
8:30 AM -
10:20 AM
CC-W181a
SPEED: Statistical Methods for Clinical Trials and Longitudinal Analysis — Contributed Speed
Biopharmaceutical Section , Biometrics Section
Chair(s): Kevin Lawson, PPD
The Poster portions will take place during Session 213223
and Session 213224
8:35 AM
Statistical Inference of Covariate-Adjusted Response-Adaptive Randomized Clinical Trials
—
Wanying Zhao, The George Washington University
8:45 AM
Adaptive Estimation of Personalized Maximum Tolerated Doses in Cancer Phase I Clinical Trials According to All Toxicities and Individual Characteristics
—
Zhengjia Chen, Emory University ; Zheng Li, Penn State University ; Ying Yuan, MD Anderson Cancer Center ; Michael Kutner, Emory University ; Taofeek Owonikoko, Emory University ; Walter J. Curran, Emory University ; Jeanne Kowalski, Emory University
8:50 AM
Small Sample Inference in Imbalanced Cluster Randomized Clinical Trials with Binary Outcomes
—
Dong Hyun Ahn, New York University ; Judith D. Goldberg, New York University School of Medicine
8:55 AM
Robust Generalized Multivariate Bioequivalence
—
Srinand Ponnathapura Nandakumar, Quintiles
9:00 AM
Explore Methodologies for Extrapolation of Efficacy from the Adult to the Specific Pediatric Population
—
Yao Li, AbbVie ; Bidan Huang, AbbVie
9:05 AM
A Clinical Trial Design Based on the Concept of Relative Time Using the Generalized Gamma Ratio Distribution
—
Milind Phadnis, University of Kansas Medical Center
9:10 AM
Improved Methods for the Marginal Analysis of Longitudinal Data in the Presence of Time-Dependent Covariates
—
I-Chen Chen, University of Kentucky ; Philip Westgate, University of Kentucky
9:15 AM
Proportional Likelihood Ratio Mixed Model
—
Hongqian Wu, University of Iowa ; Michael Jones, University of Iowa
9:20 AM
Simultaneous Confidence Intervals for Assessing SNP Effects on Treatment Efficacy
—
Yushi Liu ; Jason C. Hsu, Eli Lilly and Company/The Ohio State University
9:30 AM
Dangers of Misusing Ordinal Data
—
Ivy Liu, Victoria University of Wellington ; Daniel Fernandez Martinez, New York University ; Peter Yongqi Gu, Victoria University of Wellington
9:35 AM
A Simulation-Based Method for Detecting the Best Treatment in Clinical Trials
—
Yan Zhao, University of Oklahoma Health Sciences Center ; Roy Tamura, University of South Florida ; Michael Brown, Oklahoma Medical Research Foundation
9:45 AM
A Small N Sequential Multiple Assignment Randomized Trial for Use in Rare Disease Research
—
Roy Tamura, University of South Florida
9:50 AM
The Impact of Model Misspecification on Repeated Measures Analysis
—
Yingmei Xi, Vertex Pharmaceuticals ; John Jiang, Vertex Pharmaceuticals
9:55 AM
Correlates of Time to Sexual Debut in 15--19-Year-Olds in the Jamaica Youth Risk and Resiliency Survey 2006: A Survival Analysis
—
Tamika Royal-Thomas, University of the West Indies ; Novie Younger-Coleman, University of the West Indies ; Jan Van den Broeck, University of Bergen ; Debajyoti Sinha, Florida State University ; Daniel McGee , Florida State University ; Shelly McFarlane, University of the West Indies ; Damian Francis, University of the West Indies ; Rainford Wilks, University of the West Indies
10:05 AM
Applying Statistical Design to Improve Target Selection: An Example from Whole-Genome SiRNA Screens
—
Mandy Bergquist ; Katja Remlinger, GlaxoSmithKline
10:10 AM
Good Practices and Implementation Methods for Optimally Stratified Randomization
—
Jonathan Chipman, Vanderbilt University ; Cole Beck, Vanderbilt University ; Robert Greevy, Vanderbilt University
